Virological Success of Lopinavir/Ritonavir Salvage Regimen is Affected by an Increasing Number of Lopinavir/Ritonavir-Related Mutations

Marco Bongiovanni(Luigi Sacco Hospital), Antonella d’Arminio Monforte(University of Milan), Fulvio Adorni(Institute of Biomedical Technologies), Paola Cicconi(University of Oxford), Simona Landonio(ASST Fatebenefratelli Sacco), Laura Cordier(Luigi Sacco Hospital), Federica Tordato(Humanitas University), Stefano Rusconi(University of Milan), Teresa Bini(Ospedale San Paolo), Antonietta Cargnel(Luigi Sacco Hospital), Paola Meraviglia(Luigi Sacco Hospital), Elisabetta Chiesa(University of Milan), Amedeo Capetti(Luigi Sacco Hospital)
Antiviral Therapy
April 1, 2003
10.1177/135965350300800304
Cited by 25

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987